feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / New Screening Halts T1 Diabetes 'Crash Landings'

New Screening Halts T1 Diabetes 'Crash Landings'

21 Jan

•

Summary

  • UK to pilot pre-diabetes clinics for children using finger-prick tests.
  • Study identifies T1 diabetes markers before symptoms appear.
  • Early detection may delay insulin need for years with new treatments.
New Screening Halts T1 Diabetes 'Crash Landings'

A groundbreaking study in the UK, the Elsa study, has demonstrated the feasibility of screening children for type 1 diabetes using simple finger-prick blood tests. This research could prevent children from being diagnosed during medical emergencies, a situation currently affecting about a quarter of young T1 diabetes patients.

The Elsa study analyzed over 17,000 tests, identifying more than 200 children at risk or with indicative blood markers. This early detection allows for interventions that may delay the need for insulin treatment for years.

Plans are underway to establish NHS pre-diabetes clinics for children. These clinics will support families and educate them about early-stage T1 diabetes. Future access to treatments like teplizumab, approved in the UK last year, could further aid in delaying insulin dependency.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
trending

Chelsea beats West Ham 3-2

trending

Liverpool, Newcastle face injury woes

trending

WWE Royal Rumble in Riyadh

trending

Barcelona faces Elche in LaLiga

trending

Goretzka staying at Bayern Munich

trending

ICC T20 World Cup squads

trending

Gold, silver ETFs crashed

trending

Curran, Pandya T20Is stats compared

trending

Suryakumar Yadav T20I record

The Elsa study is assessing the feasibility of screening children for type 1 diabetes using finger-prick blood tests to detect the disease in its earliest stages.
Early diagnosis allows children to access treatments that can delay the need for insulin therapy for several years.
Yes, the study's success is paving the way for NHS pre-diabetes clinics for children identified as at risk or in the early stages of type 1 diabetes.

Read more news on

Healthside-arrow

You may also like

Breathalyzer for Blood Sugar?

18 Jan • 98 reads

article image

Add 5 Minutes Exercise: Live Longer!

15 Jan • 102 reads

article image

NHS Approves Super-Strength Wegovy Jab

13 Jan • 108 reads

article image

Insulin: The Miracle Discovery That Defied Death

11 Jan • 107 reads

article image

Patient Funds Own Transplant After NHS Refusal

16 Dec, 2025 • 230 reads

article image